John L. Knopf
2013
In 2013, John L. Knopf earned a total compensation of $2.6M as Chief Executive Officer and President at Acceleron Pharma, a 35% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $300,000 |
---|---|
Option Awards | $1,696,442 |
Salary | $400,000 |
Other | $237,461 |
Total | $2,633,903 |
Knopf received $1.7M in option awards, accounting for 64% of the total pay in 2013.
Knopf also received $300K in non-equity incentive plan, $400K in salary and $237.5K in other compensation.
Rankings
In 2013, John L. Knopf's compensation ranked 2,948th out of 12,286 executives tracked by ExecPay. In other words, Knopf earned more than 76.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,948 out of 12,286 | 76th |
Division Manufacturing | 980 out of 4,612 | 79th |
Major group Chemicals And Allied Products | 259 out of 1,462 | 82nd |
Industry group Drugs | 176 out of 1,156 | 85th |
Industry Biological Products, Except Diagnostic Substances | 25 out of 196 | 87th |
Source: SEC filing on April 15, 2016.
Knopf's colleagues
We found four more compensation records of executives who worked with John L. Knopf at Acceleron Pharma in 2013.